ROCHI

NEWS


For the drug treatment of functional dyspepsia, how to choose drugs for different groups of people and different symptoms?


Functional dyspepsia (FD) is a common functional gastrointestinal disease, which is a group of persistent or recurrent epigastric pain, epigastric burning sensation, postprandial fullness discomfort, early satiety, excessive belching, epigastric distension Gastrointestinal symptoms, such as gas and nausea, are the main manifestations, which can appear together with symptoms of gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS). Some of the onset and recurrence are related to mental and psychological factors and diet.
FD can be divided into postprandial discomfort syndrome (PDS), epigastric pain syndrome (EPS), etiology and gastrointestinal motility disorder, visceral hypersensitivity, abnormal gastric acid secretion, mucosal and immune function changes, Helicobacter pylori (Hp) Infection, changes in intestinal flora, mental and psychological factors, and abnormal regulation of the central nervous system.
This article summarizes the selection of drugs for the treatment of FD.
Drugs for the treatment of FD The
drugs for the treatment of FD mainly include antacids, prokinetic drugs, anti-Hp infection drugs, and anti-anxiety and depression drugs.
For the drug treatment of functional dyspepsia, how to choose drugs for different groups of people and different symptoms?
Drug selection for different populations
Antacids can be used for children with FD, including PPIs (such as omeprazole), H2 receptor antagonists (such as famotidine); antacids (such as aluminum magnesium carbonate); prokinetic drugs (such as domperidone, itopride); antihistamine cyproheptadine; anti-Hp infection drugs.
Elderly patients with FD can choose antacids, prokinetic drugs, anti-Hp infection drugs, anti-anxiety and depression drugs, and other therapeutic drugs such as antacids, gastric mucosal protective agents, digestive enzyme preparations, and probiotic preparations.
Drug selection for FD patients with different symptoms
Antacids (PPI, H2 receptor antagonists) and prokinetic drugs are the first-line treatment for FD.
The main symptom of Postprandial Discomfort Syndrome (PDS) is postprandial fullness or early satiety, which affects normal eating. The first-line treatment is mainly prokinetic drugs or combined with antacids.
The main symptom of epigastric pain syndrome (EPS) is epigastric pain or burning sensation, which can be induced or relieved by eating, and can also occur during fasting. The first-line treatment drugs are mainly PPI, H2 receptor antagonists, and antacids , Prokinetic drugs can be used in combination if necessary. 

Hot News


What is the process of importing raw materials?

Many customers are asking what is the process of importing raw materials? How long does the lead time take? And what kind of qualifications do you need?


For the drug treatment of functional dyspepsia, how to choose drugs for different groups of people and different symptoms?

Functional dyspepsia (FD) is a common functional gastrointestinal disease, which is a group of persistent or recurrent epigastric pain, epigastric burning sensation, postprandial fullness discomfort, early satiety, excessive belching, epigastric distension Gastrointestinal symptoms, such as gas and nausea, are the main manifestations, which can appear together with symptoms of gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS). Some of the onset and recurrence are related to mental and psychological factors and diet.


Downgraded diagnostic criteria for hypertension, and a sudden increase of 240 million patients

On November 13, my country's newly released "Clinical Practice Guidelines for Hypertension in China" (hereinafter referred to as "Guidelines") lowered the diagnostic criteria for hypertension: the original diagnostic criteria for hypertension was 140/90mmHg, and the revised one was ≥130/90mmHg. 80mmHg. In other words, the "healthy" people whose blood pressure was between 130/80 mmHg and 140/90 mmHg will completely become hypertensive patients today. Perhaps, there are not a few friends who have been "successful". A study published in 2019 showed that there are as many as 243 million people in this group in China. In the field of hypertension treatment, blockbuster drugs have always been released frequently. So, what impact will the lowering of the diagnostic criteria have on the market?


Anti-Hair loss market status

In recent years, the problem of hair loss has increasingly become a major issue that plagues young people, and finding a good cure for hair loss has become a hot topic. Among the many types of hair loss, androgenetic alopecia (AGA) is a common hair loss symptom characterized by non-scarring shrinkage of hair follicles, widely distributed in susceptible men and women, and is common One of the types of hair loss.